The quadrivalent HPV vaccine, developed by multinational pharmaceutical company Merck, was approved on Jan 8 for males on the Chinese mainland. The vaccine targets HPV types 6, 11, 16 and 18. The ...

Net profit likely fell 90 percent to 93 percent to between CNY86 million and CNY120 million (USD11.7 million to USD16.4 ...

ULAN BATOR, Jan. 24 (Xinhua) -- Mongolia has so far vaccinated at least 20,682 children aged 11 against human papillomavirus (HPV) as part of a nationwide campaign, according to a report released on ...

Several foreign drugmakers have announced debuts for their new drugs in the Chinese market since the beginning of 2025, as ...

A Shanghai lawmaker is calling for free human papillomavirus vaccinations (HPV) for girls in primary and middle school. Cervical cancer is the most prevalent female cancer in the world. In 2020, a ...

Philips CEO Roy Jakobs said he still expects subdued demand in China this year due to healthcare anti-corruption efforts by ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.

HPV can cause a variety of cancers, including cervical. New mortality data for women under 25 point to the success of the HPV vaccine.